US2019167165A1PendingUtilityA1

Analyte Monitoring Device and Methods of Use

Assignee: ABBOTT DIABETES CARE INCPriority: Nov 1, 2005Filed: Feb 8, 2019Published: Jun 6, 2019
Est. expiryNov 1, 2025(expired)· nominal 20-yr term from priority
A61B 5/1477A61B 2562/125A61B 5/742A61B 5/4848A61B 2017/3409A61B 5/4839A61B 2562/085G01N 27/3272A61B 5/746A61B 2560/0209A61B 5/0031A61B 5/7246A61B 2562/0271A61B 5/7445A61B 5/14865A61B 5/7455G01N 27/3273A61B 5/7275A61B 5/14532A61B 2560/0475A61B 5/7405A61B 5/14542A61B 5/7278A61B 2017/3407A61B 5/1495A61B 5/1473A61B 5/1451A61B 2562/0295A61B 5/7282A61B 5/14546A61B 17/3468
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method, comprising:
 receiving an analyte sensor at an analyte sensor interface;   determining, using one or more processors, a type of the analyte sensor;   recognizing, using the one or more processors, the type of the analyte sensor without a user input as a no-coding analyte sensor; and   determining, using the one or more processors, an analyte level based on one or more signals generated by the analyte sensor and a universal calibration parameter that is associated with analyte sensors that are no-coding analyte sensors.   
     
     
         2 . The method of  claim 1 , further including wirelessly receiving an analyte related data from an in vivo analyte sensor in fluid contact with a bodily fluid. 
     
     
         3 . The method of  claim 2 , further including determining an analyte level in the bodily fluid in real time based on the received analyte related data. 
     
     
         4 . The method of  claim 3 , wherein the bodily fluid includes dermal fluid. 
     
     
         5 . The method of  claim 3 , wherein the bodily fluid includes interstitial fluid. 
     
     
         6 . The method of  claim 3 , wherein the analyte level is related to one or more of a glucose level, lactate level, or oxygen level. 
     
     
         7 . The method of  claim 3 , wherein the analyte sensor includes a plurality of electrodes including a working electrode comprising an analyte-responsive enzyme. 
     
     
         8 . The method of  claim 7 , wherein the enzyme is bound to a polymer disposed on the working electrode. 
     
     
         9 . The method of  claim 7 , wherein the working electrode comprises a mediator. 
     
     
         10 . The method of  claim 9 , wherein the mediator is bound to a polymer disposed on the working electrode. 
     
     
         11 . The method of  claim 9 , wherein the mediator is crosslinked with a polymer disposed on the working electrode. 
     
     
         12 . The method of  claim 3 , wherein the analyte sensor includes a plurality of electrodes including a working electrode comprising a mediator. 
     
     
         13 . The method of  claim 12 , wherein the mediator is bound to a polymer disposed on the working electrode. 
     
     
         14 . The method of  claim 12 , wherein the mediator is crosslinked with a polymer disposed on the working electrode. 
     
     
         15 . A method, comprising:
 identifying, using one or more processors, an analyte sensor received at an analyte sensor interface of a display device without a user input as a no-coding analyte sensor;   determining, using the one or more processors, an analyte level based on one or more signals generated by the analyte sensor and a universal calibration parameter that is associated with analyte sensors that are no-coding analyte sensors; and   outputting the determined analyte level at an output unit operatively coupled to the one or more processors.   
     
     
         16 . The method of  claim 15 , further including wirelessly receiving an analyte related data from an in vivo analyte sensor in fluid contact with a bodily fluid. 
     
     
         17 . The method of  claim 16 , further including determining an analyte level in the bodily fluid in real time based on the received analyte related data. 
     
     
         18 . The method of  claim 17 , wherein the bodily fluid includes dermal fluid. 
     
     
         19 . The method of  claim 17 , wherein the bodily fluid includes interstitial fluid. 
     
     
         20 . The method of  claim 17 , wherein the analyte level is related to one or more of a glucose level, lactate level, or oxygen level.

Join the waitlist — get patent alerts

Track US2019167165A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.